GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Novonesis (Novozymes) B (OTCPK:NVZMY) » Definitions » Gross Profit

NVZMY (Novonesis (Novozymes) B) Gross Profit : $1,092 Mil (TTM As of Dec. 2024)


View and export this data going back to 2009. Start your Free Trial

What is Novonesis (Novozymes) B Gross Profit?

Novonesis (Novozymes) B's gross profit for the three months ended in Dec. 2024 was $1,092 Mil. Novonesis (Novozymes) B's gross profit for the trailing twelve months (TTM) ended in Dec. 2024 was $1,092 Mil.

Gross Margin % is calculated as gross profit divided by its revenue. Novonesis (Novozymes) B's gross profit for the three months ended in Dec. 2024 was $1,092 Mil. Novonesis (Novozymes) B's Revenue for the three months ended in Dec. 2024 was $2,096 Mil. Therefore, Novonesis (Novozymes) B's Gross Margin % for the quarter that ended in Dec. 2024 was 52.08%.

Novonesis (Novozymes) B had a gross margin of 52.08% for the quarter that ended in Dec. 2024 => Durable competitive advantage

During the past 13 years, the highest Gross Margin % of Novonesis (Novozymes) B was 58.06%. The lowest was 47.20%. And the median was 56.71%.

Warning Sign:

Novonesis (Novozymes) B gross margin has been in long-term decline. The average rate of decline per year is -2.7%.


Novonesis (Novozymes) B Gross Profit Historical Data

The historical data trend for Novonesis (Novozymes) B's Gross Profit can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Novonesis (Novozymes) B Gross Profit Chart

Novonesis (Novozymes) B Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Gross Profit
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,283.83 1,310.09 1,361.60 1,422.90 1,894.76

Novonesis (Novozymes) B Quarterly Data
Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Jun24 Dec24
Gross Profit Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 339.85 342.43 714.18 - 1,091.62

Competitive Comparison of Novonesis (Novozymes) B's Gross Profit

For the Specialty Chemicals subindustry, Novonesis (Novozymes) B's Gross Profit, along with its competitors' market caps and Gross Profit data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Novonesis (Novozymes) B's Gross Profit Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, Novonesis (Novozymes) B's Gross Profit distribution charts can be found below:

* The bar in red indicates where Novonesis (Novozymes) B's Gross Profit falls into.



Novonesis (Novozymes) B Gross Profit Calculation

Gross Profit is the different between the sale prices and the cost of buying or producing the goods.

Novonesis (Novozymes) B's Gross Profit for the fiscal year that ended in Dec. 2024 is calculated as

Gross Profit (A: Dec. 2024 )=Revenue - Cost of Goods Sold
=4014.136 - 2119.372
=1,895

Novonesis (Novozymes) B's Gross Profit for the quarter that ended in Dec. 2024 is calculated as

Gross Profit (Q: Dec. 2024 )=Revenue - Cost of Goods Sold
=2096.126 - 1004.503
=1,092

Gross Profit for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $1,092 Mil.

Gross Profit is the numerator in the calculation of Gross Margin.

Novonesis (Novozymes) B's Gross Margin % for the quarter that ended in Dec. 2024 is calculated as

Gross Margin % (Q: Dec. 2024 )=Gross Profit (Q: Dec. 2024 ) / Revenue (Q: Dec. 2024 )
=(Revenue - Cost of Goods Sold) / Revenue
=1,092 / 2096.126
=52.08 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Novonesis (Novozymes) B  (OTCPK:NVZMY) Gross Profit Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Novonesis (Novozymes) B had a gross margin of 52.08% for the quarter that ended in Dec. 2024 => Durable competitive advantage


Novonesis (Novozymes) B Gross Profit Related Terms

Thank you for viewing the detailed overview of Novonesis (Novozymes) B's Gross Profit provided by GuruFocus.com. Please click on the following links to see related term pages.


Novonesis (Novozymes) B Business Description

Address
Krogshoejvej 36, Bagsvaerd, DNK, 2880
Novonesis was formed in 2024 through the merger of Novozymes and Chr. Hansen. Following the merger, the company became the world leader in industrial enzymes and microbial solutions, with a nearly 50% market share in both. The firm supplies a wide range of industry groups: household care, food and beverages, bioenergy, agriculture and feed, technical and pharmaceuticals. Its biological solutions create value for its customers by improving yield efficiency and performance, while saving energy and generating less waste. The company is headquartered in Denmark, employs around 10,000 people, and works across more than 30 research and development and application centers and 23 manufacturing sites.

Novonesis (Novozymes) B Headlines

From GuruFocus

Q4 2023 Novozymes A/S Earnings Call Transcript

By GuruFocus Research 02-14-2024

Novonesis AS's Dividend Analysis

By GuruFocus Research 04-30-2024

Novozymes A/S Annual Shareholders Meeting Transcript

By GuruFocus Research 02-14-2024

Q3 2020 Novozymes A/S Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q2 2023 Novozymes A/S Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q2 2022 Novozymes A/S Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q3 2021 Novozymes A/S Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q1 2020 Novozymes A/S Earnings Call Transcript

By GuruFocus Research 02-14-2024

Q4 2020 Novozymes A/S Earnings Call Transcript

By GuruFocus Research 02-14-2024